Rasagiline

CHEMBL887 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

171.2 g/mol

LogP

1.8

Phase

4

A MAO-B inhibitor used to treat Parkinson's disease, either alone in early stages or combined with levodopa in more advanced disease, by increasing dopamine levels in the brain. It may also have neuroprotective properties that could slow disease progression.

Moleküler Ağırlık

171,2400 g/mol

LogP

1,80

TPSA

12,00 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Alzheimer's Disease Parkinson's Disease Schizophrenia Major Depressive Disorder

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

C#CCN[C@@H]1CCc2ccccc21

InChI

InChI=1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1

Molecular Formula

C12H13N

HBD / HBA

1 / 1

Döndürülebilir Bağlar

2

Ağır Atomlar

13

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A MAO-B inhibitor used to treat Parkinson's disease, either alone in early stages or combined with levodopa in more advanced disease, by increasing dopamine levels in the brain. It may also have neuroprotective properties that could slow disease progression.

Yes, Rasagiline is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL887. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3052776. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Rasagiline PillFYI'da

Yapı

Hızlı Veriler

Formül: C12H13N
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.